PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 280 filers reported holding PHARMACYCLICS INC in Q1 2014. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $153,906,000 | +115.6% | 601,313 | +3.0% | 0.08% | +108.3% |
| Q4 2014 | $71,372,000 | +4.1% | 583,765 | 0.0% | 0.04% | -2.7% |
| Q3 2014 | $68,552,000 | -35.5% | 583,765 | -50.7% | 0.04% | +27.6% |
| Q2 2014 | $106,228,000 | +79.0% | 1,184,112 | +100.0% | 0.03% | -12.1% |
| Q1 2014 | $59,336,000 | -5.3% | 592,056 | 0.0% | 0.03% | -8.3% |
| Q4 2013 | $62,628,000 | -25.3% | 592,056 | -2.2% | 0.04% | -26.5% |
| Q3 2013 | $83,788,000 | +302.1% | 605,319 | +130.8% | 0.05% | +276.9% |
| Q2 2013 | $20,840,000 | +18.9% | 262,237 | +20.3% | 0.01% | +18.2% |
| Q1 2013 | $17,523,000 | +24.7% | 217,914 | 0.0% | 0.01% | +22.2% |
| Q3 2012 | $14,056,000 | +10.6% | 217,914 | -8.8% | 0.01% | -10.0% |
| Q2 2012 | $12,712,000 | – | 238,908 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,010,211 | $1,245,752,000 | 17.70% |
| DAFNA Capital Management LLC | 102,128 | $14,120,000 | 15.42% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 183,390 | $25,355,000 | 4.11% |
| QVT Financial LP | 344,321 | $47,606,000 | 3.24% |
| BB BIOTECH AG | 399,030 | $55,170,000 | 3.00% |
| LMR Master Fund Ltd | 87,269 | $12,079,000 | 2.31% |
| Ithaka Group | 65,420 | $9,045,000 | 2.10% |
| Geduld E E | 22,000 | $3,042,000 | 1.86% |
| Benchmark Capital Advisors | 17,250 | $2,385,000 | 1.71% |
| HealthCor Management, L.P. | 200,000 | $27,652,000 | 1.48% |